LFCR

Dopo l'orario di chiusura: 4.34

Lifecore Biomedical Inc (LFCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Lifecore Biomedical Inc

Healthcare (1074)

(952) 368-4300

3515 LYMAN BOULEVARD, CHASKA

Prossima data di guadagno

Ultimi documenti SEC

LFCR's Discussions on Twitter

Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LFCR Lifecore Biomedical Inc	4.34	162.42M	147.12M	-33.88M	-13.62M	-0.4805
TAK Takeda Pharmaceutical Co Adr	17.44	55.06B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.94	43.07B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.08	35.88B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.92	31.59B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	527.94	26.32B	3.17B	1.29B	1.01B	27.09

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-17	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2025-09-04	Iniziato	KeyBanc Capital Markets	Sector Weight
2025-05-21	Iniziato	William Blair	Outperform
2024-09-05	Iniziato	Craig Hallum	Buy
2024-08-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2023-03-20	Downgrade	Stephens	Overweight → Equal-Weight

Mostra tutto

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

Lifecore Biomedical Inc (LFCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

LFCR|Lifecore Biomedical Inc|Price:4.330|Chg%:-0.100 - TradingKey

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical - The National Law Review

Lifecore Biomedical, Inc. Revenue Breakdown – NASDAQ:LFCR - TradingView

Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Operational ChallengesBook Value Growth - dars.gov.et

Lifecore Biomedical Inc (LFCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Lifecore Biomedical (LFCR) Q1 2026 earnings summary - Quartr

Lifecore Biomedical (LFCR) Proxy filing Summary - Quartr

LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - GuruFocus

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sahm

What Triggered Lifecore Biomedical's Recent Stock Plunge - Kavout | AI

New Lifecore Hire Gets 3,500 Stock Units Vesting in Three Years - Stock Titan

Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market - Yahoo Finance

Lifecore Biomedical (LFCR) AGM 2026 Summary - Quartr

Lifecore Biomedical (LFCR) Q2 2024 earnings summary - Quartr

Lifecore Biomedical (LFCR) Q3 2024 earnings summary - Quartr

Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: Deep EPS Miss Highlights Operational DifficultiesFull Year Guidance - dars.gov.et

Lifecore Biomedical (LFCR) Gains 3.17% as Stock Tests Key Resistance at $4.95FRAMA Signal - dars.gov.et

Lifecore Biomedical Inc. (LFCR) Drops Nearly 6% as Stock Tests Key Support LevelsFloat Adjusted Cap - dars.gov.et

Lifecore Biomedical (LFCR) Slips 3.17%: Testing Key Support at $4.65WMA Signal - dars.gov.et

LFCR Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesGross Profit Margin - dars.gov.et

LFCR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue Not DisclosedEarnings Risk Report - DonanımHaber

Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating - Moomoo

Lifecore Biomedical (LFCR) Stock Forum and Discussion - Moomoo

Form 13D/A LIFECORE BIOMEDICAL For: 2 July By Investing.com - Investing.com India

Form 13D/A Lifecore Biomedical For: 2 July By Investing.com - Investing.com Nigeria

Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026 - TradingView

Lifecore Biomedical (NASDAQ: LFCR) gets $52.1M preferred redemption requests - Stock Titan

[SCHEDULE 13D/A] LIFECORE BIOMEDICAL, INC. \DE\ Amended Major Shareholder Report - Stock Titan

(LFCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Lifecore Biomedical’s New Collaborations May Strengthen Long-Term Value ProspectsDownward Estimate Revision - dars.gov.et

Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? - Yahoo Finance

Is Now An Opportune Moment To Examine Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - simplywall.st

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review

12 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey

Enterprise value to revenue forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Price to sales forward of Lifecore Biomedical, Inc. – SWB:LDE - TradingView

Price to book forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Price to sales forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Lifecore Biomedical, Inc. Actuals & Estimates (NASDAQ:LFCR) - TradingView

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biom - The National Law Review

Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Enterprise value to EBIT forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Price to earnings forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Lifecore Biomedical, Inc. Actuals & Estimates (GETTEX:LDE) - TradingView

Lifecore Biomedical, Inc. Actuals & Estimates (BOATS:LFCR) - TradingView

LFCR Forecast — Price Target — Prediction for 2027 - TradingView

LDE Forecast — Price Target — Prediction for 2027 - TradingView

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a LFCR